LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE?

LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE?

The research objective is to determine the posterior probability of adverse cardiovascular events after elective coronary intervention in patients with ischemic heart disease (IHD) associated with type 2 diabetes, at high level of lipoprotein-associated phospholipase A2 (Lp-PLA2) in blood serum, as...

Full description

Bibliographic Details
Main Authors: A. T. Teplyakov, A. V. Kuznetsova, N. V. Protopopova, A. V. Andriyanova, T. E. Suslova, O. N. Nasanova, V. V. Kalyuzhin
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2015-04-01
Series:Bûlleten' Sibirskoj Mediciny
Subjects:
coronary artery disease
type 2 diabetes mellitus
percutaneous coronary intervention
inflammation
lipoprotein-associated phospholipase a2
prognosis
Online Access:https://bulletin.tomsk.ru/jour/article/view/131

Internet

https://bulletin.tomsk.ru/jour/article/view/131

Similar Items